GTIAS Industry Analysis Available

This NAICS code maps to a fully analysed industry with an 81-attribute GTIAS scorecard, risk scenarios, and 42+ strategic frameworks.

View Industry Analysis →

About This Industry

This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.

Cross-References. Establishments primarily engaged in--
Manufacturing packaged compounded medicinals and botanicals--are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing; and
Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.

ISIC Rev. 4 Equivalent

NAICS 325411 maps to the following ISIC Rev. 4 class:

View the full NAICS ↔ ISIC alignment table →